J Korean Neuropsychiatr Assoc.  2018 Feb;57(1):23-29. 10.4306/jknpa.2018.57.1.23.

The Clinical Significance of Cognitive Interventions for the Patients with Mild Cognitive Impairment

• Ryu SH

• KMID: 2405529
• DOI: http://doi.org/10.4306/jknpa.2018.57.1.23

Abstract

Patients with mild cognitive impairment (MCI) are at increased risk of developing dementia and Alzheimer's disease (AD). Currently, no disease-modifying or preventive drugs for AD are available. Non-pharmacological interventions, including cognitive intervention and physical exercise, could assist in the prevention and treatment of AD. Cognitive interventions can improve cognition and prevent dementia, and promote cognitive reserve and plasticity. As there are few standardized intervention programs for the treatment of MCI, development and effective study of cognitive interventions are needed. Psychiatrists should have a great interest in this kind of non-pharmacological interventions regarding neurocognitive disorders.

Keyword

Mild cognitive impairment; Alzheimer's disease; Cognitive interventions; Cognitive reserve; Cognitive plasticity

MeSH Terms

Alzheimer Disease
Cognition
Cognitive Reserve
Dementia
Exercise
Humans
Mild Cognitive Impairment*
Neurocognitive Disorders
Plastics
Psychiatry
Plastics

Figure

• 

  Fig. 1. Example of training effect of cognitive intervention. From the neuroimaging study result of metamemory training program in the elderly.

Reference

1). Ryu SH. The role of local center for dementia in the management system of dementia in Seoul. J Korean Geriatr Psychiatry. 2007; 11:12–15.

2). Lee DW. What is needed for the success of national responsibility for dementia. J Korean Med Assoc. 2017; 60:618–621.

3). Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011; 364:2227–2234.

4). Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58:1985–1992.

5). Johnson DK, Storandt M, Morris JC, Galvin JE. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol. 2009; 66:1254–1259.

6). Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016; 12:292–323.

7). Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6:734–746.

8). Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7:280–292.

9). American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed.Arlington, VA: American Psychiatric Association;2013.

10). Sowell ER, Thompson PM, Toga AW. Mapping changes in the human cortex throughout the span of life. Neuroscientist. 2004; 10:372–392.

11). Elcombe EL, Lagopoulos J, Duffy SL, Lewis SJ, Norrie L, Hickie IB, et al. Hippocampal volume in older adults at risk of cognitive decline: the role of sleep, vascular risk, and depression. J Alzheimers Dis. 2015; 44:1279–1290.

12). Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol. 2012; 8:189–202.

13). Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, et al. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology. 2009; 72:354–360.

14). Buschert V, Bokde AL, Hampel H. Cognitive intervention in Alzheimer disease. Nat Rev Neurol. 2010; 6:508–517.

15). Barnett JH, Salmond CH, Jones PB, Sahakian BJ. Cognitive reserve in neuropsychiatry. Psychol Med. 2006; 36:1053–1064.

16). Bherer L. Cognitive plasticity in older adults: effects of cognitive training and physical exercise. Ann N Y Acad Sci. 2015; 1337:1–6.

17). Lee WH, Lee WK. Cognitive rehabilitation for patients with schizophrenia in Korea. Asian J Psychiatr. 2017; 25:109–117.

18). Snowdon DA. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist. 1997; 37:150–156.

19). Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002; 8:448–460.

20). Brickman AM, Siedlecki KL, Stern Y. Cognitive and brain reserve. In: Depp CA, Jeste DV, editors. Successful cognitive and emotional aging. Arlington, VA: American Psychiatric Pub.;2010. p.157–172.

21). Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A. 2007; 104:5638–5643.

22). Stern Y, Habeck C, Moeller J, Scarmeas N, Anderson KE, Hilton HJ, et al. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex. 2005; 15:394–402.

23). Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 1993; 43:13–20.

24). Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988; 23:138–144.

25). Mori E, Hirono N, Yamashita H, Imamura T, Ikejiri Y, Ikeda M, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry. 1997; 154:18–24.

26). Noack H, Lövdén M, Schmiedek F, Lindenberger U. Cognitive plasticity in adulthood and old age: gauging the generality of cognitive intervention effects. Restor Neurol Neurosci. 2009; 27:435–453.

27). Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol. 2009; 5:649–658.

28). Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006; 7:697–709.

29). Herring A, Ambrée O, Tomm M, Habermann H, Sachser N, Paulus W, et al. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol. 2009; 216:184–192.

30). Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 2005; 15:1676–1689.

31). Charlton RA, Barrick TR, McIntyre DJ, Shen Y, O'Sullivan M, Howe FA, et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology. 2006; 66:217–222.

32). Bäckman L, Nyberg L, Lindenberger U, Li SC, Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci Biobehav Rev. 2006; 30:791–807.

33). Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001; 64:575–611.

34). Baltes PB, Schaie KW. On the plasticity of intelligence in adulthood and old age: where Horn and Donaldson fail. Am Psychol. 1976; 31:720–725.

35). Greenwood PM. Functional plasticity in cognitive aging: review and hypothesis. Neuropsychology. 2007; 21:657–673.

36). Lindenberger U, Li SC, Bäckman L. Delineating brain-behavior mappings across the lifespan: substantive and methodological advances in developmental neuroscience. Neurosci Biobehav Rev. 2006; 30:713–717.

37). Baltes PB, Lindenberger U. On the range of cognitive plasticity in old age as a function of experience: 15 years of intervention research. Behav Ther. 1988; 19:283–300.

38). Ryu SH. Psychosocial treatment of psychiatric disorders of the elderly. J Korean Med Assoc. 2010; 53:984–992.

39). Committee for New Health Technology Assessment, NECA. Cognitive intervention therapy in New Health Technology Assessment, report RR-2017-4. Sejong: Ministry and Health and Welfare;2017.

40). Clare L, Woods RT. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: a review. Neuropsychol Rehabil. 2004; 14:385–401.

41). Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, et al. Advanced Cognitive Training for Independent and Vital Elderly Study Group. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002; 288:2271–2281.

42). Lustig C, Shah P, Seidler R, Reuter-Lorenz PA. Aging, training, and the brain: a review and future directions. Neuropsychol Rev. 2009; 19:504–522.

43). Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001; 24:167–202.

44). Fotuhi M, Antoniades CB. Boost your brain: the new art and science behind enhanced brain performance. 1st ed.San Francisco, CA: Harp-erOne;2013. p. 41–62.

45). Hempel A, Giesel FL, Garcia Caraballo NM, Amann M, Meyer H, Wüstenberg T, et al. Plasticity of cortical activation related to working memory during training. Am J Psychiatry. 2004; 161:745–747.

46). Chandler MJ, Parks AC, Marsiske M, Rotblatt LJ, Smith GE. Everyday impact of cognitive interventions in mild cognitive impairment: a systematic review and metaanalysis. Neuropsychol Rev. 2016; 26:225–251.

47). Youn JH, Lee JY, Kim S, Ryu SH. Multistrategic memory training with the metamemory concept in healthy older adults. Psychiatry Investig. 2011; 8:354–361.

48). Park S, Ryu SH, Yoo Y, Yang JJ, Kwon H, Youn JH, et al. Neural predictors of cognitive improvement by multi-strategic memory training based on metamemory in older adults with subjective memory complaints. Sci Rep. 2018; 8:1095.

49). Han JW, Lee H, Hong JW, Kim K, Kim T, Byun HJ, et al. Multimodal cognitive enhancement therapy for patients with mild cognitive impairment and mild dementia: a multi- center, randomized, controlled, double-blind, crossover trial. J Alzheimers Dis. 2017; 55:787–796.